Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
Energy metabolism at whole-body, cellular, and even organelle, i.e., mitochondrial, levels requires adequate regulation in order to maintain or improve (metabolic) health. In eukaryotic cells, mitochondria are key players in energy (ATP) production via oxidative phosphorylation. Both macro- and micronutrients potentially influence energy metabolism and mitochondrial functioning, either as substrates for (oxidative) catabolism or as essential constituents of enzymes or protein complexes involved in (mitochondrial) energy metabolism. This book contains a valuable collection of empirical preclinical and human studies to assist in the development of understanding and progress this area of research on improving health and, more specifically, metabolic health.
Medicine --- insulin --- lipogenesis --- obesity --- glucose homeostasis --- adipocytes --- cortisol --- ketones --- s-IgA --- exercise --- low carbohydrate diet --- NAFLD --- omega-3 --- krill oil --- phospholipids --- high-fat diet --- C57BL/6N mice --- thermoneutral temperature --- iron deficiency --- striated skeletal muscle --- physical capacity --- fatigue --- mitochondrial metabolism --- complex I --- resting metabolic rate --- prediction equation --- ageing adults --- overweight --- adiposity-based chronic disease --- energy balance --- metabolism --- n/a
Choose an application
Energy metabolism at whole-body, cellular, and even organelle, i.e., mitochondrial, levels requires adequate regulation in order to maintain or improve (metabolic) health. In eukaryotic cells, mitochondria are key players in energy (ATP) production via oxidative phosphorylation. Both macro- and micronutrients potentially influence energy metabolism and mitochondrial functioning, either as substrates for (oxidative) catabolism or as essential constituents of enzymes or protein complexes involved in (mitochondrial) energy metabolism. This book contains a valuable collection of empirical preclinical and human studies to assist in the development of understanding and progress this area of research on improving health and, more specifically, metabolic health.
Medicine --- insulin --- lipogenesis --- obesity --- glucose homeostasis --- adipocytes --- cortisol --- ketones --- s-IgA --- exercise --- low carbohydrate diet --- NAFLD --- omega-3 --- krill oil --- phospholipids --- high-fat diet --- C57BL/6N mice --- thermoneutral temperature --- iron deficiency --- striated skeletal muscle --- physical capacity --- fatigue --- mitochondrial metabolism --- complex I --- resting metabolic rate --- prediction equation --- ageing adults --- overweight --- adiposity-based chronic disease --- energy balance --- metabolism --- n/a
Choose an application
Energy metabolism at whole-body, cellular, and even organelle, i.e., mitochondrial, levels requires adequate regulation in order to maintain or improve (metabolic) health. In eukaryotic cells, mitochondria are key players in energy (ATP) production via oxidative phosphorylation. Both macro- and micronutrients potentially influence energy metabolism and mitochondrial functioning, either as substrates for (oxidative) catabolism or as essential constituents of enzymes or protein complexes involved in (mitochondrial) energy metabolism. This book contains a valuable collection of empirical preclinical and human studies to assist in the development of understanding and progress this area of research on improving health and, more specifically, metabolic health.
insulin --- lipogenesis --- obesity --- glucose homeostasis --- adipocytes --- cortisol --- ketones --- s-IgA --- exercise --- low carbohydrate diet --- NAFLD --- omega-3 --- krill oil --- phospholipids --- high-fat diet --- C57BL/6N mice --- thermoneutral temperature --- iron deficiency --- striated skeletal muscle --- physical capacity --- fatigue --- mitochondrial metabolism --- complex I --- resting metabolic rate --- prediction equation --- ageing adults --- overweight --- adiposity-based chronic disease --- energy balance --- metabolism --- n/a
Choose an application
The present Special Issue summarizes the available scientific evidence concerning the nutrients and biomarkers in musculoskeletal diseases linked to the metabolic conditions secondary to COVID-19 confinement, osteoporosis prevention for patients with inflammatory bowel diseases, and the nutritional status in patients with spinal muscular atrophy. Furthermore, it explores the novel findings for experimental animal models of pharmacological agents to improve the regeneration of muscle tissue; acetylcholine spontaneous release located in the neuromuscular junction in mice, secondary to hypercaloric diet supplementation with an increase in spontaneous neurotransmission and the activation of myofascial trigger points associated with myofascial pain syndrome; and myogenic biomarkers in musculoskeletal conditions and gene expression associated with vitamin D and L-cysteine co-supplementation. This Special Issue is edited by a multidisciplinary group comprising the Universidad Complutense de Madrid, Universidad Rey Juan Carlos, Universidade da Coruña, and Universidad Europea de Madrid.
Humanities --- Social interaction --- COVID-19 --- acute sedentary lifestyle --- step reduction --- positive energy balance --- metabolic consequences --- insulin resistance --- metabolic syndrome --- sarcopenia --- bowel diseases --- diet --- osteoporosis --- bone density --- nutrients --- muscle unloading --- muscle reloading --- sirtuin-1 --- muscle progenitor cells --- activated satellite cells --- quiescent satellite cells --- muscle regeneration markers --- electromyography --- high-fat diet --- myofascial pain syndrome --- obesity --- spontaneous neurotransmission --- vitamin D deficiency --- l-cysteine --- glutathione --- myogenic markers --- dystrophy markers --- skeletal muscle --- spinal muscular atrophy --- metabolomics --- nutrition --- therapeutics --- biomarkers --- n/a
Choose an application
The present Special Issue summarizes the available scientific evidence concerning the nutrients and biomarkers in musculoskeletal diseases linked to the metabolic conditions secondary to COVID-19 confinement, osteoporosis prevention for patients with inflammatory bowel diseases, and the nutritional status in patients with spinal muscular atrophy. Furthermore, it explores the novel findings for experimental animal models of pharmacological agents to improve the regeneration of muscle tissue; acetylcholine spontaneous release located in the neuromuscular junction in mice, secondary to hypercaloric diet supplementation with an increase in spontaneous neurotransmission and the activation of myofascial trigger points associated with myofascial pain syndrome; and myogenic biomarkers in musculoskeletal conditions and gene expression associated with vitamin D and L-cysteine co-supplementation. This Special Issue is edited by a multidisciplinary group comprising the Universidad Complutense de Madrid, Universidad Rey Juan Carlos, Universidade da Coruña, and Universidad Europea de Madrid.
Humanities --- Social interaction --- COVID-19 --- acute sedentary lifestyle --- step reduction --- positive energy balance --- metabolic consequences --- insulin resistance --- metabolic syndrome --- sarcopenia --- bowel diseases --- diet --- osteoporosis --- bone density --- nutrients --- muscle unloading --- muscle reloading --- sirtuin-1 --- muscle progenitor cells --- activated satellite cells --- quiescent satellite cells --- muscle regeneration markers --- electromyography --- high-fat diet --- myofascial pain syndrome --- obesity --- spontaneous neurotransmission --- vitamin D deficiency --- l-cysteine --- glutathione --- myogenic markers --- dystrophy markers --- skeletal muscle --- spinal muscular atrophy --- metabolomics --- nutrition --- therapeutics --- biomarkers --- n/a
Choose an application
The present Special Issue summarizes the available scientific evidence concerning the nutrients and biomarkers in musculoskeletal diseases linked to the metabolic conditions secondary to COVID-19 confinement, osteoporosis prevention for patients with inflammatory bowel diseases, and the nutritional status in patients with spinal muscular atrophy. Furthermore, it explores the novel findings for experimental animal models of pharmacological agents to improve the regeneration of muscle tissue; acetylcholine spontaneous release located in the neuromuscular junction in mice, secondary to hypercaloric diet supplementation with an increase in spontaneous neurotransmission and the activation of myofascial trigger points associated with myofascial pain syndrome; and myogenic biomarkers in musculoskeletal conditions and gene expression associated with vitamin D and L-cysteine co-supplementation. This Special Issue is edited by a multidisciplinary group comprising the Universidad Complutense de Madrid, Universidad Rey Juan Carlos, Universidade da Coruña, and Universidad Europea de Madrid.
COVID-19 --- acute sedentary lifestyle --- step reduction --- positive energy balance --- metabolic consequences --- insulin resistance --- metabolic syndrome --- sarcopenia --- bowel diseases --- diet --- osteoporosis --- bone density --- nutrients --- muscle unloading --- muscle reloading --- sirtuin-1 --- muscle progenitor cells --- activated satellite cells --- quiescent satellite cells --- muscle regeneration markers --- electromyography --- high-fat diet --- myofascial pain syndrome --- obesity --- spontaneous neurotransmission --- vitamin D deficiency --- l-cysteine --- glutathione --- myogenic markers --- dystrophy markers --- skeletal muscle --- spinal muscular atrophy --- metabolomics --- nutrition --- therapeutics --- biomarkers --- n/a
Choose an application
The control of energy metabolism is a central event for cell, organ, and organism survival. There are many control levels in energy metabolism, although in this Special Issue, we concentrated on the neuroendocrine control which is operated through specialized neural circuits controlling both food intake and energy expenditure. Due to the explosion of obesity and associated diseases, the subject of this Special Issue is of particular interest today.
Medicine --- Neurosciences --- IGF1 --- IGF2 --- IGFBP2 --- high-fat diet --- obesity --- sex differences --- neuropeptides --- beige adipocyte --- white adipocyte --- brown adipocyte --- diabetes mellitus --- differentiation --- kisspeptin --- AgRP --- sheep --- reproduction --- LH --- genistein --- proopiomelanocortin --- arcuate nucleus --- rats --- endocrine disrupting chemicals --- bisphenol A --- diethylstilbestrol --- tributyltin --- neuropeptide Y --- pro-opiomelanocortin --- phytoestrogens --- endocrine disruptor --- dimorphism --- POMC --- orexin --- subfornical organ --- organum vasculosum of the lamina terminalis --- area postrema --- hypothalamus --- metabolism --- diabetes --- estrogens --- gut permeability/integrity --- insulin sensitivity --- Akkermansia --- gut microbiome --- lactate --- glycogen --- behavior --- learning --- astrocytes --- calcium signaling --- energy balance --- gliotransmission --- systemic metabolism --- amygdala --- kisspeptins --- food intake --- body weight --- intrauterine growth restriction --- macrosomia --- glucose tolerance --- abdominal adipocyte gene expression --- thrifty phenotype hypothesis
Choose an application
The control of energy metabolism is a central event for cell, organ, and organism survival. There are many control levels in energy metabolism, although in this Special Issue, we concentrated on the neuroendocrine control which is operated through specialized neural circuits controlling both food intake and energy expenditure. Due to the explosion of obesity and associated diseases, the subject of this Special Issue is of particular interest today.
Medicine --- Neurosciences --- IGF1 --- IGF2 --- IGFBP2 --- high-fat diet --- obesity --- sex differences --- neuropeptides --- beige adipocyte --- white adipocyte --- brown adipocyte --- diabetes mellitus --- differentiation --- kisspeptin --- AgRP --- sheep --- reproduction --- LH --- genistein --- proopiomelanocortin --- arcuate nucleus --- rats --- endocrine disrupting chemicals --- bisphenol A --- diethylstilbestrol --- tributyltin --- neuropeptide Y --- pro-opiomelanocortin --- phytoestrogens --- endocrine disruptor --- dimorphism --- POMC --- orexin --- subfornical organ --- organum vasculosum of the lamina terminalis --- area postrema --- hypothalamus --- metabolism --- diabetes --- estrogens --- gut permeability/integrity --- insulin sensitivity --- Akkermansia --- gut microbiome --- lactate --- glycogen --- behavior --- learning --- astrocytes --- calcium signaling --- energy balance --- gliotransmission --- systemic metabolism --- amygdala --- kisspeptins --- food intake --- body weight --- intrauterine growth restriction --- macrosomia --- glucose tolerance --- abdominal adipocyte gene expression --- thrifty phenotype hypothesis
Choose an application
The control of energy metabolism is a central event for cell, organ, and organism survival. There are many control levels in energy metabolism, although in this Special Issue, we concentrated on the neuroendocrine control which is operated through specialized neural circuits controlling both food intake and energy expenditure. Due to the explosion of obesity and associated diseases, the subject of this Special Issue is of particular interest today.
IGF1 --- IGF2 --- IGFBP2 --- high-fat diet --- obesity --- sex differences --- neuropeptides --- beige adipocyte --- white adipocyte --- brown adipocyte --- diabetes mellitus --- differentiation --- kisspeptin --- AgRP --- sheep --- reproduction --- LH --- genistein --- proopiomelanocortin --- arcuate nucleus --- rats --- endocrine disrupting chemicals --- bisphenol A --- diethylstilbestrol --- tributyltin --- neuropeptide Y --- pro-opiomelanocortin --- phytoestrogens --- endocrine disruptor --- dimorphism --- POMC --- orexin --- subfornical organ --- organum vasculosum of the lamina terminalis --- area postrema --- hypothalamus --- metabolism --- diabetes --- estrogens --- gut permeability/integrity --- insulin sensitivity --- Akkermansia --- gut microbiome --- lactate --- glycogen --- behavior --- learning --- astrocytes --- calcium signaling --- energy balance --- gliotransmission --- systemic metabolism --- amygdala --- kisspeptins --- food intake --- body weight --- intrauterine growth restriction --- macrosomia --- glucose tolerance --- abdominal adipocyte gene expression --- thrifty phenotype hypothesis
Choose an application
High-quality primary data publications and review articles have been selected for publication in this Special Issue. They, collectively, draw a comprehensive picture of some of the most relevant questions linking (healthy) nutrition to brain development and brain disorders.
Medicine --- Neurosciences --- cocaine self-administration --- high-fat diet --- high-sugar diet --- maternal diet --- pregnancy and lactation --- melanocortin-4 receptor --- offspring brain --- rat offspring --- maternal nutrition --- protein restriction --- fetal brain --- hypothalamus --- differentiation --- neurogenesis --- transcriptomics --- epitranscriptomics --- mitochondria --- PKU --- cognitive outcomes --- cross-cultural --- cross-countries --- Phe associations --- spearmint --- rosmarinic acid --- polyphenol --- amyloid fibril --- amyloid beta --- alpha-synuclein --- Tau --- dementia --- human milk oligosaccharides --- cognition --- brain development --- animal behaviour --- fucosyllactose --- sialyllactose --- long term potentiation --- gut–brain–axis --- gut microbiome --- short-chain fatty acids --- bacterial metabolites --- SCFA --- manganese --- blood–brain barrier --- blood–cerebrospinal fluid barrier --- choroid plexus --- ketogenic supplement --- ketosis --- aging --- lifespan --- neurodegenerative disease --- learning --- memory --- early childhood --- nutrition --- Mediterranean diet --- body mass index --- cognitive development --- multi-omics --- microvascular --- brain --- high glycemic diet --- soluble epoxide hydrolase inhibitor --- maless --- depression --- affective disorder --- gut-brain-axis --- bacteria --- probiotics --- therapy --- treatment --- n/a --- blood-brain barrier --- blood-cerebrospinal fluid barrier
Listing 1 - 10 of 13 | << page >> |
Sort by
|